Existing therapies for major depression have a lag of onset of action of several weeks, resulting in considerable morbidity. Exploring pharmacological strategies that have rapid onset of antidepressant effects within a few days and that are sustained would have an enormous impact on patient care. Converging lines of evidence suggest the role of the glutamatergic system in the pathophysiology and treatment of mood disorders.
Popular Blog Posts
End The Stigma!
Lady Gaga and Bradley Cooper did a masterful remake of “A Star is Born”, now in theaters. We highly…
Dr. Sanjay Gupta on CNN: “Ketamine offers lifeline for people with severe depression, suicidal thoughts”
In this post, a Wisconsin man who had been on the brink of suicide, told CNN’s Sanjay Gupta how…
The Resurgence of Psychedelics in Medicine
There has been a flurry of articles in the media recently touting the successful use of psychedelics in medicine.…
Ketamine Infusions Provide Effective Relief for Severe Chronic Headache
Medical research is revealing more and more applications for ketamine, the old drug being used in new ways. Just…
New Insight Into How Ketamine Works in Depression
Ketamine exerts an initial antidepressant effect by blocking the N-methyl-D-aspartate receptor (NMDAR), and the ketamine metabolite hydroxynorketamine (HNK) may extend…
Leave a Reply